24 results
8-K
EX-99.1
CFRXQ
CONTRAFECT Corp
14 May 21
ContraFect Reports First Quarter 2021 Financial Results and Provides Business Update
4:55pm
the appointment of Jane F. Barlow, MD, MPH, MBA to the Company’s board of directors. Dr. Barlow is an expert in drug launch readiness and pricing
8-K
EX-10.1
1anlz
12 Mar 21
ContraFect Announces BARDA Contract Award for Up to $86.8 Million and Provides Business Outlook
8:30am
424B5
cbm8eyh
26 May 20
Prospectus supplement for primary offering
4:39pm
424B5
x3y85dkb82wc6
21 May 20
Prospectus supplement for primary offering
5:23pm
8-K
EX-1.1
rbh7vtwrjr07yuc4k
19 Dec 19
Other Events
4:17pm
8-K
EX-1.1
j6kth38k
12 Dec 19
Entry into a Material Definitive Agreement
5:03pm
10-K
l42fy9ok m7op
26 Mar 15
Annual report
12:00am
8-K
r1cpv9 jd2
21 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-1.1
vpwm kjg37j8qu8x1
1 Aug 14
Contrafect Announces Pricing of Its
12:00am
424B1
gfd87xd
29 Jul 14
Prospectus with pricing info
12:00am